144 related articles for article (PubMed ID: 34806539)
21. CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages.
Yang Y; Ma B; Li L; Jin Y; Ben W; Zhang D; Jiang K; Feng S; Huang L; Zheng J
Oncol Rep; 2014 Jun; 31(6):2759-68. PubMed ID: 24700371
[TBL] [Abstract][Full Text] [Related]
22. [Vector construction and silencing effect of Edg4 gene targeted small interfering RNA in ovarian cancer cell line].
Qiao YH; Li LX; Guo RX; Zhou W; Wang M; Zhang XY; Zhang JH; Zhao XL; Zhang MZ; Zhao GQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):765-9. PubMed ID: 18307905
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer.
Shan YS; Hsu HP; Lai MD; Hung YH; Wang CY; Yen MC; Chen YL
Oncol Lett; 2017 Oct; 14(4):4517-4526. PubMed ID: 28943959
[TBL] [Abstract][Full Text] [Related]
24. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
25. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
Zhang L; Sun D; Zhang J; Tian Y
Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.
Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E
Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422
[TBL] [Abstract][Full Text] [Related]
28. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
[TBL] [Abstract][Full Text] [Related]
29. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
Li N; Zeng J; Sun F; Tong X; Meng G; Wu C; Ding X; Liu L; Han M; Lu C; Dai F
Cell Cycle; 2018; 17(19-20):2335-2348. PubMed ID: 30317923
[TBL] [Abstract][Full Text] [Related]
30. [Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].
Deng KX; Zhong L; Jiang MX; Chen WX; Chen Y; He H
Ai Zheng; 2005 Aug; 24(8):945-50. PubMed ID: 16086871
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.
Orhan C; Bulut P; Dalay N; Ersen E; Buyru N
Mol Biol Rep; 2019 Oct; 46(5):5251-5256. PubMed ID: 31321645
[TBL] [Abstract][Full Text] [Related]
32. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
Li Z; Wang Q; Zhang W; Yang Z; Li L
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):854-60. PubMed ID: 26887775
[TBL] [Abstract][Full Text] [Related]
33. Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells.
Guo FJ; Tian JY; Jin YM; Wang L; Yang RQ; Cui MH
Mol Med Rep; 2015 Jan; 11(1):59-66. PubMed ID: 25335121
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cells.
Huang YS; Wang TX; Lin XM; Wang H; Li RZ; Zeng X; Zhu C; Chen LK; Guo Q; Liu H; Wu XP
Anticancer Drugs; 2019 Nov; 30(10):973-982. PubMed ID: 31503014
[TBL] [Abstract][Full Text] [Related]
36. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel.
Li S; Zhao X; Chang S; Li Y; Guo M; Guan Y
Int J Oncol; 2019 Jan; 54(1):249-260. PubMed ID: 30431082
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
38. Targeting cleavage and polyadenylation specific factor 1 via shRNA inhibits cell proliferation in human ovarian cancer.
Zhang B; Liu Y; Liu D; Yang L
J Biosci; 2017 Sep; 42(3):417-425. PubMed ID: 29358555
[TBL] [Abstract][Full Text] [Related]
39. Expression profile and prognostic value of SFN in human ovarian cancer.
Hu Y; Zeng Q; Li C; Xie Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30926680
[TBL] [Abstract][Full Text] [Related]
40. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
Gregory-Bass RC; Olatinwo M; Xu W; Matthews R; Stiles JK; Thomas K; Liu D; Tsang B; Thompson WE
Int J Cancer; 2008 May; 122(9):1923-30. PubMed ID: 18183577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
